Troy Edward Wilson net worth and biography

Troy Wilson Biography and Net Worth

Director of Avidity Biosciences

Troy Wilson is a successful, serial entrepreneur with a passion to build exceptional companies that create significant value for patients, employees and shareholders. He co-founded Avidity Biosciences (NASDAQ: RNA) and has served as chairman of our board of directors since our inception. Dr. Wilson currently serves as President and Chief Executive Officer and Chairman of Kura Oncology (NASDAQ: KURA). Previously, he co-founded and served as President and CEO of Araxes Pharma LLC and Wellspring Biosciences, where he and his team pioneered the discovery and development of small molecules inhibitors of the KRAS oncoprotein. Earlier in his career, Dr. Wilson co-founded and served as President and CEO of Intellikine, a private biopharmaceutical company, acquired by Takeda Pharmaceutical Company Limited in 2011, and he co-founded and served as chief business officer of Ambrx (NASDAQ: AMAM), acquired by Johnson & Johnson Innovative Medicines in 2024. Dr. Wilson holds a J.D. from New York University and graduated with a Ph.D. in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley.

What is Troy Edward Wilson's net worth?: The estimated net worth of Troy Edward Wilson is at least $17.66 million as of September 29th, 2025. Dr. Wilson owns 246,853 shares of Avidity Biosciences stock worth more than $17,659,864 as of December 4th. This net worth estimate does not reflect any other assets that Dr. Wilson may own. Additionally, Dr. Wilson receives an annual salary of $70,000.00 as Director at Avidity Biosciences. Learn More about Troy Edward Wilson's net worth.
How old is Troy Edward Wilson?: Dr. Wilson is currently 55 years old. There are 7 older executives and no younger executives at Avidity Biosciences. The oldest executive at Avidity Biosciences is Dr. Frank P. McCormick Ph.D., Scientific Founder & Member of Scientific Advisory Board, who is 74 years old. Learn More on Troy Edward Wilson's age.
What is Troy Edward Wilson's salary?: As the Director of Avidity Biosciences, Inc., Dr. Wilson earns $70,000.00 per year. There are 5 executives that earn more than Dr. Wilson. The highest earning executive at Avidity Biosciences is Ms. Sarah Boyce, President, CEO & Director, who commands a salary of $998,880.00 per year. Learn More on Troy Edward Wilson's salary.
How do I contact Troy Edward Wilson?: The corporate mailing address for Dr. Wilson and other Avidity Biosciences executives is 10975 N. TORREY PINES RD. SUITE 150, LA JOLLA CA, 92037. Avidity Biosciences can also be reached via phone at 858-401-7900 and via email at [email protected]. Learn More on Troy Edward Wilson's contact information.
Has Troy Edward Wilson been buying or selling shares of Avidity Biosciences?: Troy Edward Wilson has not been actively trading shares of Avidity Biosciences within the last three months. Most recently, Troy Edward Wilson sold 29,500 shares of the business's stock in a transaction on Friday, September 5th. The shares were sold at an average price of $50.00, for a transaction totalling $1,475,000.00. Following the completion of the sale, the director now directly owns 54,425 shares of the company's stock, valued at $2,721,250. Learn More on Troy Edward Wilson's trading history.
Who are Avidity Biosciences' active insiders?: Avidity Biosciences' insider roster includes Sarah Boyce (President & CEO), W. Flanagan (Insider), Kathleen Gallagher (Insider), Steven Hughes (Insider), Arthur Levin (Insider), Michael MacLean (Chief Financial and Chief Business Officer), Teresa Mccarthy (Insider), John Moriarty, Jr. (Chief Legal Officer and Corporate Secretary), Eric Mosbrooker (Chief Commercial Officer), Tamar Thompson (Director), and Troy Wilson (Director). Learn More on Avidity Biosciences' active insiders.
Are insiders buying or selling shares of Avidity Biosciences?: During the last year, insiders at the biotechnology company sold shares 35 times. They sold a total of 788,205 shares worth more than $33,292,671.98. The most recent insider tranaction occured on October, 22nd when insider Steven George Hughes sold 2,209 shares worth more than $105,015.86. Insiders at Avidity Biosciences own 3.8% of the company. Learn More about insider trades at Avidity Biosciences.
Information on this page was last updated on 10/22/2025.

Troy Edward Wilson Insider Trading History at Avidity Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/5/2025	Sell	29,500	$50.00	$1,475,000.00	54,425
8/6/2025	Sell	29,500	$45.00	$1,327,500.00	69,425
8/6/2025	Sell	65,554	$45.00	$2,949,930.00	17,776

Troy Edward Wilson Buying and Selling Activity at Avidity Biosciences

Avidity Biosciences Company Overview

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $71.54

$71.42

$71.69

50 Day Range

MA: $60.79

$42.63

$71.58

2 Week Range

Now: $71.54

$21.51

$71.78

Volume

2,514,106 shs

Average Volume

2,988,567 shs

Market Capitalization

$10.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Troy Wilson Biography and Net Worth

What is Troy Edward Wilson's net worth?

How old is Troy Edward Wilson?

What is Troy Edward Wilson's salary?

How do I contact Troy Edward Wilson?

Has Troy Edward Wilson been buying or selling shares of Avidity Biosciences?

Who are Avidity Biosciences' active insiders?

Are insiders buying or selling shares of Avidity Biosciences?